Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 18840806)

Published in J Gerontol A Biol Sci Med Sci on September 01, 2008

Authors

Angela M Abbatecola1, Michelangela Barbieri, Maria R Rizzo, Rodolfo Grella, Maria T Laieta, Emma Quaranta, Anna M Molinari, Michele Cioffi, Paola Fioretto, Giuseppe Paolisso

Author Affiliations

1: Department of Geriatric Medicine and Metabolic Diseases, Second University of Naples, Italy, Piazza Miraglia 2, I-80138 Naples, Italy.

Articles by these authors

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation (2002) 3.84

Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc (2012) 3.77

Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab (2003) 2.51

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care (2012) 2.43

Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab (2003) 2.40

Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations. J Diabetes Complications (2009) 2.33

Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol (2002) 2.23

Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes (2003) 2.16

Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol (2005) 2.00

"The older, the wiser" in prostate cancer treatment choices? Ann Intern Med (2013) 1.96

Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes (2003) 1.92

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88

Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. Hypertension (2007) 1.77

Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab (2002) 1.76

Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol (2009) 1.67

Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol (2005) 1.63

Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet (2009) 1.61

Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61

Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients. Atherosclerosis (2009) 1.51

Cancer stem cells in solid tumors. Semin Cancer Biol (2010) 1.51

Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev (2005) 1.49

Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med (2003) 1.48

Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr (2003) 1.41

Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res (2009) 1.38

Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc (2004) 1.36

Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol (2013) 1.36

Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci (2005) 1.36

European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab (2011) 1.34

Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc (2004) 1.32

Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. PLoS One (2013) 1.29

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res (2008) 1.27

Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res (2004) 1.27

Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care (2010) 1.23

Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20

Mediterranean diet, telomere maintenance and health status among elderly. PLoS One (2013) 1.15

Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol (2006) 1.14

Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation (2013) 1.13

High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis (2006) 1.13

Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc (2006) 1.13

The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol (2009) 1.11

Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders. Eur J Heart Fail (2013) 1.10

Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial. Diabetes Care (2006) 1.10

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer (2002) 1.10

Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol (2006) 1.09

Glucose regulation and oxidative stress in healthy centenarians. Exp Gerontol (2003) 1.08

Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. BMC Cardiovasc Disord (2014) 1.07

Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab (2005) 1.07

Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract (2013) 1.05

Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res (2007) 1.04

The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg (2004) 1.04

Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity. Exp Gerontol (2004) 1.03

Effects of nitric oxide on cell proliferation: novel insights. J Am Coll Cardiol (2013) 1.03

Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol (2010) 1.01

The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol (2002) 1.01

Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction. J Clin Endocrinol Metab (2012) 1.00

Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol (2004) 1.00

Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab (2006) 1.00

Functional role of miRNA in cardiac resynchronization therapy. Pharmacogenomics (2014) 1.00

Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care (2003) 1.00

Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjects. Mech Ageing Dev (2009) 0.99

Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age (Dordr) (2011) 0.99

Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis (2007) 0.98

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. Diabetes Care (2010) 0.98

Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis. Eur J Endocrinol (2003) 0.97

Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol (2004) 0.97

Mediterranean diet and mobility decline in older persons. Exp Gerontol (2010) 0.95

Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients. Diabetes Care (2009) 0.95

Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care (2005) 0.95

Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti study. J Am Geriatr Soc (2009) 0.95

Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care (2013) 0.95